The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors. - Carucci, Margherita; Clamp, Andrew; Zhou, Cong; Hurt, Chris; Glasspool, Rosalind; Monaghan, Phillip J.; Thirkettle, Sally; Wheatley, Michael; Mahmood, Madia; Narasimham, Monica; Cox, Tracy; Morrison, Hilary; et al. (BMC Cancer, 2024)